The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mohty, M.
Right arrow Articles by Gaugler, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mohty, M.
Right arrow Articles by Gaugler, B.
The Journal of Immunology, 2003, 171: 3385-3393.
Copyright © 2003 by The American Association of Immunologists

IFN-{alpha} Skews Monocyte Differentiation into Toll-Like Receptor 7-Expressing Dendritic Cells with Potent Functional Activities1

Mohamad Mohty*, Alexandra Vialle-Castellano*, Jacques A. Nunes{dagger}, Daniel Isnardon*, Daniel Olive*,{dagger} and Béatrice Gaugler2,*,{dagger}

* Laboratoire d’Immunologie des Tumeurs, Institut Paoli-Calmettes, Université de la Méditerranée, and {dagger} Institut National de la Santé et de la Recherche Médicale Unité 119, Marseille, France

IFN-{alpha} is an important cytokine for the generation of a protective T cell-mediated immune response to viruses. In this study, we asked whether IFN-{alpha} can regulate the functional properties of dendritic cells (DCs). We show that monocytes cultured in the presence of GM-CSF and IFN-{alpha} can differentiate into DCs (IFN-{alpha}-derived DCs (IFN-DCs)). When compared with DCs generated in the presence of GM-CSF and IL-4 (IL-4-derived DCs), IFN-DCs exhibited a typical DC morphology and expressed, in addition to DC markers CD1a and blood DC Ag 4, a similar level of costimulatory and class II MHC molecules, but a significantly higher level of MHC class I molecules. After maturation with CD40 ligand, IFN-DCs up-regulated costimulatory, class I and II MHC molecules and expressed mature DC markers such as CD83 and DC-lysosome-associated membrane protein. IFN-DCs were endowed with potent functional activities. IFN-DCs secreted large amounts of the inflammatory cytokines IL-6, IL-10, TNF-{alpha}, IL-1{beta}, and IL-18, and promoted a Th1 response that was independent of IL-12p70 and IL-18, but substantially inhibited by IFN-{alpha} neutralization. Furthermore, immature IFN-DCs induced a potent autologous Ag-specific immune response, as evaluated by IFN-{gamma} secretion and expansion of CD8+ T cells specific for CMV. Also, IFN-DCs expressed a large number of Toll-like receptors (TLRs), including acquisition of TLR7, which is classically found on the natural type I IFN-producing plasmacytoid DCs. Like plasmacytoid DCs, IFN-DCs could secrete IFN-{alpha} following viral stimulation or TLR7-specific stimulation. Taken together, these results illustrate the critical role of IFN-{alpha} at the early steps of immune response to pathogens or in autoimmune diseases.




This article has been cited by other articles:


Home page
J. Immunol.Home page
H. Qiu, Y. Fan, A. G. Joyee, S. Wang, X. Han, H. Bai, L. Jiao, N. Van Rooijen, and X. Yang
Type I IFNs Enhance Susceptibility to Chlamydia muridarum Lung Infection by Enhancing Apoptosis of Local Macrophages
J. Immunol., August 1, 2008; 181(3): 2092 - 2102.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
S. S. Mohapatra and S. Boyapalle
Epidemiologic, Experimental, and Clinical Links between Respiratory Syncytial Virus Infection and Asthma
Clin. Microbiol. Rev., July 1, 2008; 21(3): 495 - 504.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Zeng, H. Li, Y. Liu, Z. Zhang, Y. Zhang, and R. Yang
Tumor-Induced Suppressor of Cytokine Signaling 3 Inhibits Toll-like Receptor 3 Signaling in Dendritic Cells via Binding to Tyrosine Kinase 2
Cancer Res., July 1, 2008; 68(13): 5397 - 5404.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
L. F. Zhang, K. Okuma, R. Tanaka, A. Kodama, K. Kondo, A. A. Ansari, and Y. Tanaka
Generation of Mature Dendritic Cells with Unique Phenotype and Function by In Vitro Short-Term Culture of Human Monocytes in the Presence of Interleukin-4 and Interferon-{beta}
Experimental Biology and Medicine, June 1, 2008; 233(6): 721 - 731.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Papewalis, B. Jacobs, M. Wuttke, E. Ullrich, T. Baehring, R. Fenk, H. S. Willenberg, S. Schinner, M. Cohnen, J. Seissler, et al.
IFN-{alpha} Skews Monocytes into CD56+-Expressing Dendritic Cells with Potent Functional Activities In Vitro and In Vivo
J. Immunol., February 1, 2008; 180(3): 1462 - 1470.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
U. Sriram, C. Biswas, E. M. Behrens, J.-A. Dinnall, D. K. Shivers, M. Monestier, Y. Argon, and S. Gallucci
IL-4 Suppresses Dendritic Cell Response to Type I Interferons
J. Immunol., November 15, 2007; 179(10): 6446 - 6455.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. F. Denny, S. Thacker, H. Mehta, E. C. Somers, T. Dodick, F. J. Barrat, W. J. McCune, and M. J. Kaplan
Interferon-{alpha} promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis
Blood, October 15, 2007; 110(8): 2907 - 2915.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Severa, M. E. Remoli, E. Giacomini, V. Annibali, V. Gafa, R. Lande, M. Tomai, M. Salvetti, and E. M. Coccia
Sensitization to TLR7 Agonist in IFN-beta-Preactivated Dendritic Cells
J. Immunol., May 15, 2007; 178(10): 6208 - 6216.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Hu and L. B. Ivashkiv
Costimulation of Chemokine Receptor Signaling by Matrix Metalloproteinase-9 Mediates Enhanced Migration of IFN-{alpha} Dendritic Cells
J. Immunol., May 15, 2006; 176(10): 6022 - 6033.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Di Pucchio, L. Pilla, I. Capone, M. Ferrantini, E. Montefiore, F. Urbani, R. Patuzzo, E. Pennacchioli, M. Santinami, A. Cova, et al.
Immunization of Stage IV Melanoma Patients with Melan-A/MART-1 and gp100 Peptides plus IFN-{alpha} Results in the Activation of Specific CD8+ T Cells and Monocyte/Dendritic Cell Precursors.
Cancer Res., May 1, 2006; 66(9): 4943 - 4951.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
F. Nimura, L. F. Zhang, K. Okuma, R. Tanaka, H. Sunakawa, N. Yamamoto, and Y. Tanaka
Cross-linking cell surface chemokine receptors leads to isolation, activation, and differentiation of monocytes into potent dendritic cells.
Experimental Biology and Medicine, April 1, 2006; 231(4): 431 - 443.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. H. V. G. Gil, I. H. Ansari, V. Vassilev, D. Liang, V. C. H. Lai, W. Zhong, Z. Hong, E. J. Dubovi, and R. O. Donis
The Amino-Terminal Domain of Bovine Viral Diarrhea Virus Npro Protein Is Necessary for Alpha/Beta Interferon Antagonism
J. Virol., January 15, 2006; 80(2): 900 - 911.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. Urosevic, R. Dummer, C. Conrad, M. Beyeler, E. Laine, G. Burg, and M. Gilliet
Disease-Independent Skin Recruitment and Activation of Plasmacytoid Predendritic Cells Following Imiquimod Treatment
J Natl Cancer Inst, August 3, 2005; 97(15): 1143 - 1153.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Omatsu, T. Iyoda, Y. Kimura, A. Maki, M. Ishimori, N. Toyama-Sorimachi, and K. Inaba
Development of Murine Plasmacytoid Dendritic Cells Defined by Increased Expression of an Inhibitory NK Receptor, Ly49Q
J. Immunol., June 1, 2005; 174(11): 6657 - 6662.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. B. Bekeredjian-Ding, M. Wagner, V. Hornung, T. Giese, M. Schnurr, S. Endres, and G. Hartmann
Plasmacytoid Dendritic Cells Control TLR7 Sensitivity of Naive B Cells via Type I IFN
J. Immunol., April 1, 2005; 174(7): 4043 - 4050.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. B. Gorden, K. S. Gorski, S. J. Gibson, R. M. Kedl, W. C. Kieper, X. Qiu, M. A. Tomai, S. S. Alkan, and J. P. Vasilakos
Synthetic TLR Agonists Reveal Functional Differences between Human TLR7 and TLR8
J. Immunol., February 1, 2005; 174(3): 1259 - 1268.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. McKenna, A.-S. Beignon, and N. Bhardwaj
Plasmacytoid Dendritic Cells: Linking Innate and Adaptive Immunity
J. Virol., January 1, 2005; 79(1): 17 - 27.
[Full Text] [PDF]


Home page
J. Immunol.Home page
N. Dikopoulos, A. Bertoletti, A. Kroger, H. Hauser, R. Schirmbeck, and J. Reimann
Type I IFN Negatively Regulates CD8+ T Cell Responses through IL-10-Producing CD4+ T Regulatory 1 Cells
J. Immunol., January 1, 2005; 174(1): 99 - 109.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
M. Gilliet, C. Conrad, M. Geiges, A. Cozzio, W. Thurlimann, G. Burg, F. O. Nestle, and R. Dummer
Psoriasis Triggered by Toll-like Receptor 7 Agonist Imiquimod in the Presence of Dermal Plasmacytoid Dendritic Cell Precursors
Arch Dermatol, December 1, 2004; 140(12): 1490 - 1495.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
C. Carbonneil, H. Saidi, V. Donkova-Petrini, and L. Weiss
Dendritic cells generated in the presence of interferon-{alpha} stimulate allogeneic CD4+ T-cell proliferation: modulation by autocrine IL-10, enhanced T-cell apoptosis and T regulatory type 1 cells
Int. Immunol., July 1, 2004; 16(7): 1037 - 1052.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
N. Teleshova, J. Jones, J. Kenney, J. Purcell, R. Bohm, A. Gettie, and M. Pope
Short-term Flt3L treatment effectively mobilizes functional macaque dendritic cells
J. Leukoc. Biol., June 1, 2004; 75(6): 1102 - 1110.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.